An East Kilbride mother is taking on a skipping challenge to raise funds for Cancer Research UK, touching the hearts of many with her inspiring initiative. Amanda Meechan, 55, has committed to skipping 100 times a day throughout October, aiming to raise £1000 for the cancer charity. Her motivation comes from a personal place, as she honours her late father, Billy Masterson, who passed away from cancer eight years ago, and celebrates her sister Deborah Loughran’s triumph over breast cancer.
Amanda has not only embraced the skipping challenge but has also taken it a step further by skipping her way around various locations in Glasgow and beyond, sharing her journey on social media. She expressed, “When I heard of the 100 skips a day for Cancer Research I thought I can do this challenge…I found myself enjoying this and decided to make it more fun and interesting, going somewhere different each day to skip in and around Glasgow, and sometimes further afield.” Her skipping locations include famous spots like George Square, Glasgow Green, The Barras, STV Studios, The Kelpies, Hampden Park, and even atop Conic Hill in Balmaha.
The challenge has not only been a physical feat for Amanda but also a means to spread awareness and raise significant funds for cancer research. Her dedication and creativity have garnered tremendous support from friends, family, and the community, propelling her fundraising efforts closer to reaching her ambitious target. Amanda’s efforts stand as a testament to the power of personal drive and community spirit in making a difference in the fight against cancer.
In conclusion, Amanda Meechan’s skipping challenge for Cancer Research UK exemplifies the extraordinary lengths individuals go to support causes close to their hearts. Her creative approach to fundraising, coupled with her personal connection to cancer, has resonated with many and inspired others to contribute towards lifesaving research. Amanda’s determination and positivity serve as a shining example of how ordinary people can make an extraordinary impact in the ongoing battle against cancer.